Brain+ A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRAINP.CO research report →
About the company
Brain+ A/S specializes in developing digital therapeutic solutions for individuals coping with Alzheimer's and various types of dementia. The company's portfolio includes Cognitive Stimulation Therapy (CST), which targets the primary symptoms of dementia, and Computerized Cognitive Training, a method designed for patients experiencing mild cognitive impairment. Additionally, Brain+ offers "Starry Night," a memory assessment tool crucial for the early detection and continuous monitoring of Alzheimer's disease.
- CEO
- Devika Wood
- IPO
- 2021
- Employees
- 20
- HQ
- Copenhagen, DK
Price Chart
- Market Cap
- $4.76M
- P/E
- -0.09
- P/S
- 11.85
- P/B
- 0.13
- EV/EBITDA
- -0.04
- Div Yield
- 0.00%
- Gross Margin
- -256.58%
- Op Margin
- -3207.73%
- Net Margin
- -3234.15%
- ROE
- -102.10%
- ROIC
- -39.54%
- Revenue
- $7.86M · 234.05%
- Net Income
- $-12,045,412 · 37.02%
- EPS
- $-0.09 · 81.98%
- Op Income
- $-11,660,536
- FCF YoY
- 22.02%
- 52W High
- $0.07
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- -0.50
- Avg Volume
- 16.58M
Get TickerSpark's AI analysis on BRAINP.CO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BRAINP.CO coverage
Recent articles, reports, and earnings notes.
No research on BRAINP.CO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BRAINP.CO report →